Role of Progastrins and Gastrins and Their Receptors in GI and Pancreatic Cancers: Targets for Treatment

E-ISSN： 1873-4286|10|19|2345-2358

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.19, 2004-07, pp. : 2345-2358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer

By Spears Melanie Bartlett John

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 6, 2009-06 ,pp. : 665-674

Informa Healthcare

Access to resources Recommend Favorite

Melanocortin Receptors as Targets in the Treatment of Obesity

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1098-1110

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptide Y receptors as targets of obesity treatment

By Ishihara PhD Akane Moriya PhD Minoru MacNeil PhD Douglas J Fukami PhD Takehiro Kanatani PhD Akio

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. : 1701-1712

Informa Healthcare

Access to resources Recommend Favorite

Neurokinin Receptors as Potential Targets in Breast Cancer Treatment

Current Drug Discovery Technologies, Vol. 5, Iss. 1, 2008-03 ,pp. : 15-19

Bentham Science Publishers

Access to resources Recommend Favorite

Methionine Aminopeptidases as Potential Targets for Treatment of Gastrointestinal Cancers and other Tumors

Current Drug Targets, Vol. 11, Iss. 11, 2010-11 ,pp. : 1439-1457

Bentham Science Publishers

Access to resources Recommend Favorite